Kamada Ltd. (TLV:KMDA)
2,602.00
+10.00 (0.39%)
Apr 6, 2026, 2:28 PM IDT
Kamada Revenue
In the year 2025, Kamada had annual revenue of $180.46M USD with 12.12% growth. Kamada had revenue of $44.68M in the quarter ending December 31, 2025, with 14.54% growth.
Revenue
$180.46M
Revenue Growth
+12.12%
P/S Ratio
2.61
Revenue / Employee
$390.61K
Employees
462
Market Cap
1.50B ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 180.46M | 19.51M | 12.12% |
| Dec 31, 2024 | 160.95M | 18.43M | 12.93% |
| Dec 31, 2023 | 142.52M | 13.18M | 10.19% |
| Dec 31, 2022 | 129.34M | 25.70M | 24.79% |
| Dec 31, 2021 | 103.64M | -29.60M | -22.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.02B |
| Danel (Adir Yeoshua) | 2.90B |
| Novolog (Pharm-Up 1966) | 1.81B |
| Ilex Medical | 930.83M |
| SofWave Medical | 279.39M |
| BrainsWay | 166.49M |
| Bait Bakfar | 109.62M |
| Golden House | 46.05M |
Kamada News
- 8 days ago - Kamada (KMDA) Secures Favorable Tax Ruling on Cash Dividend - GuruFocus
- 13 days ago - Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas - GlobeNewsWire
- 4 weeks ago - Kamada Ltd (KMDA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Outlook - GuruFocus
- 4 weeks ago - Q4 2025 Kamada Ltd Earnings Call Transcript - GuruFocus
- 4 weeks ago - Kamada (KMDA) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - Nasdaq
- 4 weeks ago - Kamada Shares Slip Despite Record FY25 Results And Dividend Declaration - Nasdaq
- 4 weeks ago - Earnings Scheduled For March 11, 2026 - Benzinga
- 4 weeks ago - Kamada Reports Record Top- and Bottom-line 2025 Financial Results and Affirms 2026 Guidance Representing Continued Double-Digit Organic Profitable Growth - GlobeNewsWire